Máj- és epeúti rák: vizsgálatok itt: Kína
621 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 66
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07063888 - 1/2. fázisTaking peopleCRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
- Where
- Beijing
- Életkor
- 16 év to 85 év
- People
- 90
- Run by
- AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
See details and how to joinNCT07053488 - No phaseCsak meghívásosThe Efficacy of Sequential RT After Triple Therapy for uHCC
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 35
- Run by
- Fujian Provincial Hospital
See details and how to joinNCT07052448 - 2. fázisTaking peopleLenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 146
- Run by
- Fudan University
See details and how to joinNCT07047586 - 1/2. fázisTaking peopleClinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 40
- Run by
- Shanghai Public Health Clinical Center
See details and how to joinNCT03093688 - 2. fázisTaking peopleJS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma
- Where
- Beijing, Changsha, Harbin, Hefei, Nanchang, Shanghai, Shenyang, Zhengzhou
- Életkor
- 18 év and over
- People
- 72
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06954467 - 2. fázisTaking peopleA Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 46
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06978114 - No phaseNot yet taking people in KínaHAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 28
- Run by
- RenJi Hospital
See details and how to joinNCT07045558 - No phaseCsak meghívásosAI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 300
- Run by
- Beijing Tsinghua Chang Gung Hospital
See details and how to joinNCT07042841 - No phaseTaking peopleD-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 37
- Run by
- Fujian Provincial Hospital
See details and how to joinNCT06643208 - 1. fázisNot yet taking people in KínaA Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 66
- Run by
- Shanghai Bao Pharmaceuticals Co., Ltd.
See details and how to joinNCT07036185 - 1. fázisTaking peoplePIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 25
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07018518 - 2. fázisTaking peopleSequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07025174 - No phaseTaking peopleBile Omics for Diagnosing Indeterminate Biliary Strictures
- Where
- Shanghai
- Életkor
- 18 év to 90 év
- People
- 260
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07007832 - No phaseTaking peopleHead-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City
- Where
- Zhongshan
- Életkor
- 35 év and over
- People
- 4500
- Run by
- Zhongshan People's Hospital, Guangdong, China
See details and how to joinNCT07010198 - No phaseNot yet taking people in KínaComparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk
- Where
- Beijing, Changchun, Chongqing, Handan, Harbin, Jinan, Qingdao, Tianjin, Wuhan, Xi'an, Xishuangbanna Dai Autonomous Prefecture
- Életkor
- 18 év to 75 év
- People
- 1389
- Run by
- Peking University People's Hospital
See details and how to joinNCT07010588 - 2. fázisNot yet taking people in KínaIparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis
- Where
- Beijing
- Életkor
- 18 év to 79 év
- People
- 54
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07007728 - No phaseNot yet taking people in KínaReal-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer
- Where
- Anfu, Ankang, Anning, Anqing, Anshan, Anyue, Baise City, Baoding, Baotou, Beihai, Beijing, Bengbu, Benxi, Bihua, Binzhou, Bozhou, Cangzhou, Changchun, Changji, Changle, Changxing, Changzhi, Changzhou, Chaoyang, Chengdu, Chifeng, Chizhou, Chuzhou, Dali, Dalian, Dandong, Daqing, Datong, Donggang, Dongguan, Dongtai, Dongying, Enshi, Ezhou, Fengcheng, Fenyang, Foshan, Fuxin, Fuyang, Fuzhou, Ganzhou, Gaomi, Guangzhou, Guilin, Haikou, Hailin, Hami, Handan, Hangzhou, Hanzhong, Harbin, Hebei, Hefei, Hegang, Heihe, Heilongjiang, Hengshui, Hetian, Heze, Hezhou, Hohhot, Huai'an, Huainan, Huangshan City, Huangshi, Hubei, Huozhou, Jiamusi, Ji’an, Jiangmen, Jianping, Jiaozhou, Jiexiu, Jilin City, Jimo, Jinan, Jincheng, Jingzhou, Jinhua, Jining, Jinxian, Jinzhong, Jinzhou, Jiujiang, Jixi, Junxian, Karamay, Kunming, Laixi, Laizhou, Lanzhou, Lianyungang, Linfen, Linkou, Linxia, Linyi, Lishui, Liuzhou, Longnan, Longyan, Lu'an, Lüliang, Ma’anshan, Macheng, Maoming, Meishan, Mudanjiang, Nanchang, Nanchong, Nangong, Nanjing, Nanning, Nanping, Nantong, Neimeng, Ningbo, Ningcheng, Ordos, Panjin, Pingdu, Pingliang, Pingxiang, Pingyang, Putian, Qingdao, Qingyuan, Qingzhou, Qinhuangdao, Qinzhou, Qiqihar, Quanzhou, Rizhao, Rui’an, Sanming, Shandong, Shangcheng, Shanghai, Shangli, Shangrao, Shawan, Shenyang, Shenzhen, Shijiazhuang, Shiyan, Shouguang, Sichuan, Songyuan, Suqian, Suzhou, Tai’an, Taihe, Taiyuan, Taizhou, Tangshan, Tengzhou, Tianjin, Tongjiang, Tongliao, Tongling, Ürümqi, Weifang, Weihai, Wenzhou, Wu’an, Wuhai, Wuhan, Wuwei, Wuxi, Wuzhou, Xiamen, Xi'an, Xi’an, Xiaogan, Xingtai, Xining, Xinjiang, Xintai, Xiushui, Xizang, Xuancheng, Xuzhou, Yanan, Yanbian, Yancheng, Yangquan, Yangzhou, Yantai, Yibin, Yichang, Yichun, Yinchuan, Yingkou, Yingtan, Yining, Yizheng, Yulin, Yuncheng, Zaozhuang, Zhangjiakou, Zhanjiang, Zhenjiang, Zhongshan, Zibo, Zigong, Zouping
- Életkor
- 30 év and over
- People
- 1500
- Run by
- Peking University First Hospital
See details and how to joinNCT07007286 - 2. fázisTaking peopleClinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 25
- Run by
- Liu Huang
See details and how to joinNCT06199895 - No phaseCsak meghívásosAdjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma(AICRC)
- Where
- XiAn
- Életkor
- 18 év to 70 év
- People
- 10
- Run by
- Hengchao Yu
See details and how to joinNCT06997913 - No phaseTaking peopleGemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment (BTC-IM-1)
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 100
- Run by
- Fudan University
See details and how to joinNCT06988592 - 1/2. fázisTaking peoplePersonalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Zhejiang University
See details and how to joinNCT06995105 - No phaseTaking peopleEvaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
- Where
- Beijing
- Életkor
- 18 év to 85 év
- People
- 99
- Run by
- Peking University Third Hospital
See details and how to joinNCT06277531 - 2. fázisNot yet taking people in KínaIvonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06993025 - 1/2. fázisNot yet taking people in KínaHepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT06741020